Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

Authors :: Creutzberg, C. L.
Leon-Castillo, A.
de Boer, S. M.
Powell, M. E.
Mileshkin, L. R.
Mackay, H. J.
Leary, A.
Nijman, H. W.
Singh, N.
Pollock, P.
Fyles, A.
Haie-Meder, C.
Smit, V. T. H. B. M.
Edmondson, R. J.
Putter, H.
Kitchener, H. C.
Crosbie, E. J.
de Bruyn, M.
Nout, R.
Bosse, T.
Targeted Gynaecologic Oncology (TARGON)
Translational Immunology Groningen (TRIGR)
Source :: Annals of Oncology, 30, 899-900. Oxford University Press
Publication Year :: 2019

Tools